Meeting News CoveragePerspectivePublication Exclusive

Disparities identified among women who undergo immediate breast reconstruction

HemOnc Today, October 25, 2012
Compared with patients who did not undergo reconstruction, women who underwent tissue expander reconstruction or pedicled flaps reconstruction were…
Meeting News CoveragePerspectivePublication Exclusive

Demographic factors associated with decision to undergo CPM

HemOnc Today, October 25, 2012
SAN FRANCISCO — Prior research has shown risk factors such as younger age and family history of breast cancer contributed to patients’…
Meeting News CoveragePerspectivePublication Exclusive

Patient survey: Sexual dysfunction neglected in routine care

HemOnc Today, October 25, 2012
SAN FRANCISCO — Sexual dysfunction, a documented consequence of breast cancer treatment, was not fully addressed during follow-up routine care…
Meeting News CoveragePerspectivePublication Exclusive

Novel therapy improved PFS for patients with advanced breast cancer

HemOnc Today, October 1, 2012
SAN FRANCISCO — The novel therapy trastuzumab emtansine significantly improved PFS compared with capecitabine and lapatinib in patients with…
Meeting News Coverage

IOERT delivered safely in early, low-risk disease

HemOnc Today, October 1, 2012
SAN FRANCISCO — Accelerated partial-breast irradiation using a single dose of intraoperative electron radiotherapy can be performed safely in…
Meeting News CoveragePerspectivePublication Exclusive

Axillary lymph node removal may benefit women at high risk for residual nodal disease

HemOnc Today, October 25, 2012
SAN FRANCISCO — A subset of breast cancer patients with high risk for residual nodal involvement after surgery may be candidates for axillary…
Meeting News CoveragePerspectivePublication Exclusive

Research raises questions about expensive staging modalities

HemOnc Today, October 1, 2012
SAN FRANCISCO — Although bone scan, liver ultrasound and chest X-ray frequently are used as staging tests, they were associated with low…
Meeting News CoveragePerspectivePublication Exclusive

Device may reduce re-excision rate in breast cancer surgery

HemOnc Today, October 1, 2012
SAN FRANCISCO — A novel device intended to provide surgeons with real-time detection of cancerous tissues at the margins of excised breast…
Meeting News Coverage

21-gene recurrence score may predict outcomes in ER-positive, node-positive patients

HemOnc Today, October 1, 2012
SAN FRANCISCO — The 21-gene recurrence score may help clinicians target node-positive, ER-positive breast cancer patients who are at high…